BackSofiva Genomics ,Ltd. Overview

Sofiva Genomics ,Ltd. Total Current Liabilities

Sofiva Genomics ,Ltd.'s total current liabilities is $69M.

Get informed when a big investor buys or sells

+ Follow
Total Current Liabilities
$69.19M
↓ 18.94% YoYΔ $-16.16M vs prior year quarter

Peer trimmed avg / median

Loading

Sofiva Genomics ,Ltd. Total Current Liabilities History

Loading

Sofiva Genomics ,Ltd. vs. peers: Total Current Liabilities Comparison

Loading

Sofiva Genomics ,Ltd. Total Current Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Sofiva Genomics ,Ltd. (6615.TWO) FAQ

The latest total current liabilities for 6615.TWO is $69M as of June 2026. That compares with $85M in the prior-year period — down 18.9% year over year. Investors often review this figure alongside Sofiva Genomics ,Ltd.'s historical trend and sector peers before judging valuation or financial health.

Over the past year, 6615.TWO's total current liabilities moved from $85M to $69M — a 18.9% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Sofiva Genomics ,Ltd.'s operating scale or balance-sheet position.

A total current liabilities figure of $69M for 6615.TWO is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting 6615.TWO's total current liabilities ($69M), review year-over-year change from $85M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.